Company:Owkin
From HandWiki
 | |
| Founded | August 3, 2016 |
|---|---|
| Founder | Gilles Wainrib, Thomas Clozel |
| Headquarters | Paris , France |
Area served | US, France, UK, Switzerland |
| Products | Owkin Platform |
| Owner | Sanofi, BPI France, Cathay Innovation, MACSF, GV, F-Prime Capital, Eight Roads |
Number of employees | 172 (2022) |
| Website | owkin |
Owkin is a medical A.I. company created in 2016[1] that develops a federated learning A.I. platform to help pharmaceutical companies discover new drugs.[2] Owkin has collaborated with Amgen to demonstrate the ability of A.I. to improve cardiovascular prediction.[3]
Company history
Owkin was founded in 2016, by Gilles Wainrib, a professor of Artificial Intelligence, and Thomas Clozel, a clinical research doctor and son of Jean-Paul and Martine Clozel founders of Swiss biotech Actelion.[4]
Fund Raising
- October 30, 2016: The company raises a $2.1 million seed round from friends and family and NJF Capital
- January 16, 2018: The company raises a $11 million series A round with new investors Otium Capital, Cathay Innovation; GV[5]
- May 23, 2018: The company raises a $5 million extension series A round with GV
- March 7, 2019: The company raises a $13 million extension series A round with Eight Roads Venture[6]
- May 7, 2020: The company raises a $35 million extension series A round with MACSF, BPI France
- July 1, 2020: The company raises a $18 million extension series A round with Mubadala Capital Ventures
- November 18, 2021: The company raises a $180 million corporate round with Sanofi
Valuation
Owkin has raised over $255 million and became a ‘unicorn’ [7] – a startup valued at more than $1 billion – in November 2021 through a $180 million investment from French biopharma company Sanofi.
References
- ↑ "OWKIN FRANCE (PARIS 10) Chiffre d'affaires, résultat, bilans sur SOCIETE.COM - 822393591". https://www.societe.com/societe/owkin-france-822393591.html.
- ↑ Council, Jared (2020-05-11). "Intel, Health Institutions to Use Emerging AI Technique to Improve Tumor Detection" (in en-US). Wall Street Journal. ISSN 0099-9660. https://www.wsj.com/articles/intel-health-institutions-to-use-emerging-ai-technique-to-improve-tumor-detection-11589191200.
- ↑ "Amgen, Owkin Use AI to Improve Cardiovascular Risk Prediction". https://www.contractpharma.com/contents/view_breaking-news/2021-12-17/amgen-owkin-use-ai-to-improve-cardiovascular-risk-prediction/.
- ↑ "Owkin heads to Basel" (in en-US). https://baselarea.swiss/blog-post/owkin-heading-to-basel/.
- ↑ "OWKIN Closes $11 Million Series A Financing Round" (in en-US). https://www.cathaycapital.com/press-room/owkin-closes-11-million-series-a-financing-round/.
- ↑ "Owkin - enabling breakthrough medical research" (in en). https://eightroads.com/news/owkin-enabling-breakthrough-medical-research.
- ↑ Rosemain, Mathieu (2021-11-18). "Drugmaker Sanofi invests $180 mln in French AI startup Owkin" (in en). Reuters. https://www.reuters.com/business/healthcare-pharmaceuticals/drugmaker-sanofi-invests-180-mln-french-ai-startup-owkin-2021-11-18/.
 |
